• Michael Obladen


Die früher übliche strenge Trennung in pränatale und postnatale Infektionen ist weitgehend aufgegeben. Infektionen sind beim Neugeborenen – und noch mehr beim Frühgeborenen – häufig, da sowohl die humorale als auch die zelluläre Immunität nicht ausgereift ist. Die häufigsten und schwerwiegendsten Infektionen werden knapp geschildert. Die Entstehung nosokomialer Infektionen und das zu ihrer Verringerung entwickelte Krankenhaus-Infektions-Surveillance-System werden dargestellt.


  1. 1.
    Aebi-Popp K, Mulcahy F, Rudin C et al. (2013) National Guidelines for the prevention of mother-to-child transmission of HIV across Europe – how do countries differ? Eur J Public Health 23(6):1053–8Google Scholar
  2. 2.
    Albanyan EA, Baker CJ (1998) Is lumbar puncture necessary to exclude meningitis in neonates and young infants: lessons from the group B streptococcus cellulitis- adenitis syndrome. Pediatrics 102(4 Pt 1):985–6Google Scholar
  3. 3.
    American Academy of Pediatrics Committee on Infectious Diseases (2014) Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection. Pediatrics 134(2):415–20Google Scholar
  4. 4.
    Andabaka T, Nickerson JW, Rojas-Reyes MX, Rueda JD, Bacic Vrca V, Barsic B (2013) Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. Cochrane Database Syst Rev 4:CD006602Google Scholar
  5. 5.
    Austin N, Cleminson J, Darlow BA, McGuire W (2015) Prophylactic oral/topical non-absorbed antifungal agents to prevent invasive fungal infection in very low birth weight infants. Cochrane Database Syst Rev 10:CD003478Google Scholar
  6. 6.
    Buchholz B, Beichert M, Marcus U et al. (2009) German-Austrian recommendations for HIV1-therapy in pregnancy and in HIV1-exposed newborn, update 2008. Eur J Med Res 14(11):461–79Google Scholar
  7. 7.
    Buhrer C, Bahr S, Siebert J, Wettstein R, Geffers C, Obladen M (2002) Use of 2 % 2-phenoxyethanol and 0.1% octenidine as antiseptic in premature newborn infants of 23-26 weeks gestation. J Hosp Infect 51(4):305–7Google Scholar
  8. 8.
    Cailes B, Vergnano S, Kortsalioudaki C, Heath P, Sharland M (2015) The current and future roles of neonatal infection surveillance programmes in combating antimicrobial resistance. Early Hum Dev 91(11):613–8Google Scholar
  9. 9.
    Capparelli EV, Mirochnick M, Dankner WM et al. (2003) Pharmacokinetics and tolerance of zidovudine in preterm infants. J Pediatr 142(1):47–52Google Scholar
  10. 10.
    Carr R, Modi N, Dore C (2003) G-CSF and GM-CSF for treating or preventing neonatal infections. Cochrane Database Syst Rev (3):CD003066Google Scholar
  11. 11.
    Celik IH, Demirel FG, Uras N et al. (2010) What are the cut-off levels for IL-6 and CRP in neonatal sepsis? J Clin Lab Anal 24(6):407–12Google Scholar
  12. 12.
    Cernada M, Badia N, Modesto V et al. (2012) Cord blood interleukin-6 as a predictor of early-onset neonatal sepsis. Acta Paediatr 101(5):e203–7Google Scholar
  13. 13.
    Cleminson J, Austin N, McGuire W (2015) Prophylactic systemic antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev 10:CD003850Google Scholar
  14. 14.
    Clerihew L, McGuire W (2012) Antifungal therapy for newborn infants with invasive fungal infection. Cochrane Database Syst Rev 6:CD003953Google Scholar
  15. 15.
    Davies MW, Mehr S, Garland ST, Morley CJ (2000) Bacterial colonization of toys in neonatal intensive care cots. Pediatrics 106(2):E18Google Scholar
  16. 16.
    Dunn D, Wallon M, Peyron F, Petersen E, Peckham C, Gilbert R (1999) Mother-to-child transmission of toxoplasmosis: risk estimates for clinical counselling. Lancet 353(9167):1829–33Google Scholar
  17. 17.
    European Collaborative Study (2004) Levels and patterns of neutrophil cell counts over the first 8 years of life in children of HIV-1-infected mothers. AIDS 18(15):2009–17Google Scholar
  18. 18.
    Fernandes RM, Bialy LM, Vandermeer B et al. (2013) Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 6:CD004878Google Scholar
  19. 19.
    Flores G, Horwitz RI (1997) Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics 100(2 Pt 1):233–9Google Scholar
  20. 20.
    Foster JP, Richards R, Showell MG, Jones LJ (2015) Intravenous in-line filters for preventing morbidity and mortality in neonates. Cochrane Database Syst Rev 8:CD005248Google Scholar
  21. 21.
    Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections, 1988. Am J Infect Control 16(3):128–40Google Scholar
  22. 22.
    Goelz R, Hihn E, Hamprecht K et al. (2009) Effects of different CMV-heat-inactivation-methods on growth factors in human breast milk. Pediatr Res 65(4):458–61Google Scholar
  23. 23.
    Grosch-Worner I, Schafer A, Obladen M et al. (2000) An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection. AIDS 14(18):2903–11Google Scholar
  24. 24.
    Hansen A, Forbes P, Arnold A, O’Rourke E (2003) Once-daily gentamicin dosing for the preterm and term newborn: proposal for a simple regimen that achieves target levels. J Perinatol 23(8):635–9Google Scholar
  25. 25.
    Hartling L, Bialy LM, Vandermeer B et al. (2011) Epinephrine for bronchiolitis. Cochrane Database Syst Rev (6):CD003123Google Scholar
  26. 26.
    Ho HJ, Poh BF, Choudhury S, Krishnan P, Ang B, Chow A (2015) Alcohol handrubbing and chlorhexidine handwashing are equally effective in removing methicillin-resistant Staphylococcus aureus from health care workers’ hands: A randomized controlled trial. Am J Infect Control 43(11):1246–8Google Scholar
  27. 27.
    Inglis GD, Jardine LA, Davies MW (2007) Prophylactic antibiotics to reduce morbidity and mortality in neonates with umbilical artery catheters. Cochrane Database Syst Rev (4):CD004697Google Scholar
  28. 28.
    Inglis GD, Jardine LA, Davies MW (2007) Prophylactic antibiotics to reduce morbidity and mortality in ventilated newborn infants. Cochrane Database Syst Rev (3):CD004338Google Scholar
  29. 29.
    Kamitsuka MD, Nugent NA, Conrad PD, Swanson TN (1995) Candida albicans brain abscesses in a premature infant treated with amphotericin B, flucytosine and fluconazole. Pediatr Infect Dis J 14(4):329–31Google Scholar
  30. 30.
    Kaufman DA, Morris A, Gurka MJ, Kapik B, Hetherington S (2014) Fluconazole prophylaxis in preterm infants: a multicenter case-controlled analysis of efficacy and safety. Early Hum Dev 90 Suppl 1:S87–90Google Scholar
  31. 31.
    Kimberlin DW, Aban I, Acosta EP (2015) Valganciclovir for congenital cytomegalovirus. N Engl J Med 372(25):2463Google Scholar
  32. 32.
    Kimberlin DW, Lin CY, Sanchez PJ et al. (2003) Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 143(1):16–25Google Scholar
  33. 33.
    Leviton A, Allred EN, Fichorova RN, Kuban KC, Michael O’Shea T, Dammann O (2016) Systemic inflammation on postnatal days 21 and 28 and indicators of brain dysfunction 2years later among children born before the 28th week of gestation. Early Hum Dev 93:25–32Google Scholar
  34. 34.
    Malathi I, Millar MR, Leeming JP, Hedges A, Marlow N (1993) Skin disinfection in preterm infants. Arch Dis Child 69(3 Spec No):312–6Google Scholar
  35. 35.
    McAuley JB (2014) Congenital toxoplasmosis. J Pediatric Infect Dis Soc 3 Suppl 1:S30–5Google Scholar
  36. 36.
    Mombro M, Perathoner C, Leone A et al. (2003) Congenital toxoplasmosis: assessment of risk to newborns in confirmed and uncertain maternal infection. Eur J Pediatr 162(10):703–6Google Scholar
  37. 37.
    Nduati R, Richardson BA, John G et al. (2001) Effect of breastfeeding on mortality among HIV-1 infected women: a randomised trial. Lancet 357(9269):1651–5Google Scholar
  38. 38.
    Odio CM, Puig JR, Feris JM et al. (1999) Prospective, randomized, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children. Meropenem Meningitis Study Group. Pediatr Infect Dis J 18(7):581–90Google Scholar
  39. 39.
    Ohlsson A, Lacy JB (2013) Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infants. Cochrane Database Syst Rev 7:CD000361Google Scholar
  40. 40.
    Ohlsson A, Lacy JB (2015) Intravenous immunoglobulin for suspected or proven infection in neonates. Cochrane Database Syst Rev 3:CD001239Google Scholar
  41. 41.
    Oliver SE, Cloud GA, Sanchez PJ et al. (2009) Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol 46 Suppl 4:S22–6Google Scholar
  42. 42.
    Olsen AL, Reinholdt J, Jensen AM, Andersen LP, Jensen ET (2009) Nosocomial infection in a Danish Neonatal Intensive Care Unit: a prospective study. Acta Paediatr 98(8):1294–9Google Scholar
  43. 43.
    Pammi M, Brocklehurst P (2011) Granulocyte transfusions for neonates with confirmed or suspected sepsis and neutropenia. Cochrane Database Syst Rev (10):CD003956Google Scholar
  44. 44.
    Pammi M, Haque KN (2015) Pentoxifylline for treatment of sepsis and necrotizing enterocolitis in neonates. Cochrane Database Syst Rev 3:CD004205Google Scholar
  45. 45.
    Pan CQ, Duan Z, Dai E et al. (2016) Tenofovir to prevent Hepatitis B transmission in mothers with high viral load. N Engl J Med 374(24): 2324–34Google Scholar
  46. 46.
    Pittet D, Allegranzi B, Boyce J (2009) The World Health Organization Guidelines on Hand Hygiene in Health Care and their consensus recommendations. Infect Control Hosp Epidemiol 30(7):611–22Google Scholar
  47. 47.
    Rao SC, Srinivasjois R, Hagan R, Ahmed M (2011) One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst Rev (11):CD005091Google Scholar
  48. 48.
    Schmitz T, Weizsaecker K, Feiterna-Sperling C, Eilers E, Obladen M (2006) Exposure to HIV and antiretroviral medication as a potential cause of necrotizing enterocolitis in term neonates. AIDS 20 (7):1082–3Google Scholar
  49. 49.
    Schwab F, Geffers C, Barwolff S, Ruden H, Gastmeier P (2007) Reducing neonatal nosocomial bloodstream infections through participation in a national surveillance system. J Hosp Infect 65(4):319–25Google Scholar
  50. 50.
    Shah SS, Ohlsson A, Shah VS (2012) Intraventricular antibiotics for bacterial meningitis in neonates. Cochrane Database Syst Rev 7:CD004496Google Scholar
  51. 51.
    Siegfried N, van der Merwe L, Brocklehurst P, Sint TT (2011) Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev (7):CD003510Google Scholar
  52. 52.
    Soheilian M, Sadoughi MM, Ghajarnia M et al. (2005) Prospective randomized trial of trimethoprim/sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis. Ophthalmology 112(11):1876–82Google Scholar
  53. 53.
    Ventre K, Randolph AG (2007) Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children. Cochrane Database Syst Rev (1):CD000181Google Scholar
  54. 54.
    Villena I, Ancelle T, Delmas C et al. (2010) Congenital toxoplasmosis in France in 2007: first results from a national surveillance system. Euro Surveill 15(25)Google Scholar
  55. 55.
    Webster J, Pritchard MA (2003) Gowning by attendants and visitors in newborn nurseries for prevention of neonatal morbidity and mortality. Cochrane Database Syst Rev (3):CD003670Google Scholar
  56. 56.
    Wei HX, Wei SS, Lindsay DS, Peng HJ (2015) A systematic review and meta-analysis of the efficacy of anti-Toxoplasma gondii medicines in humans. PLoS One 10(9):e0138204Google Scholar

Copyright information

© Springer-Verlag GmbH Deutschland 2017

Authors and Affiliations

  • Michael Obladen
    • 1
  1. 1.Klinik für NeonatologieBerlin

Personalised recommendations